Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/7/2022 | $28.00 → $30.00 | Buy | HC Wainwright & Co. |
| 11/15/2021 | $27.00 → $28.00 | Buy | HC Wainwright & Co. |
| 8/9/2021 | $30.00 → $27.00 | Buy | HC Wainwright & Co. |
HC Wainwright & Co. reiterated coverage of Meridian Bioscience with a rating of Buy and set a new price target of $30.00 from $28.00 previously
HC Wainwright & Co. reiterated coverage of Meridian Bioscience with a rating of Buy and set a new price target of $28.00 from $27.00 previously
HC Wainwright & Co. reiterated coverage of Meridian Bioscience with a rating of Buy and set a new price target of $27.00 from $30.00 previously
3 - VivoPower PLC (0001681348) (Issuer)
4 - MERIDIAN BIOSCIENCE INC (0000794172) (Issuer)
4 - MERIDIAN BIOSCIENCE INC (0000794172) (Issuer)
6-K - VivoPower PLC (0001681348) (Filer)
6-K/A - VivoPower PLC (0001681348) (Filer)
6-K - VivoPower PLC (0001681348) (Filer)
Mr. Harris was the lead battery responsible engineer at SpaceX, leading the engineering team that developed the battery systems of the Falcon 9 rocket, Cargo Dragon, and Crew Dragon spacecraft Appointment to Advisory Council bolsters VivoPower's power systems and battery engineering expertise across its sovereign AI data center platform, including operational Nordic sites as well as for Tembo, its electric vehicle business LONDON, June 02, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (NASDAQ:VIVO) ("VivoPower" or the "Company"), a B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications, today announced the appointment of Porter Har
New tenant(s) expected to further improve data center economics for VivoPower beyond its current annual $31 million in revenues and $10 million in EBITDA—transaction expected to be finalized by June 30, 2026 Short list follows the completion of a lease bidding process, which fielded firm proposals that were stronger and broader than anticipated Board also received and evaluated unsolicited offers to acquire the asset at a premium to VivoPower's acquisition price, which were rejected Board considers strategic value to be materially higher, given the asset has amongst the lowest power costs for data centers in Europe and the world Operational 41.5MW with a further 40MW expected to be ene
VivoPower's presentation is scheduled for Wednesday, May 20, 2026, at 11:00 AM ET LONDON, May 14, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (NASDAQ:VIVO) ("VivoPower" or the "Company"), a B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications, announced today that its senior management team will present at KBRA's European Data Centers Event. Alex Cuppage, Chief Investment Officer, will represent VivoPower at the event on Wednesday, 20 May 2026. VivoPower's presentation is scheduled from 11:00 AM ET to 11:45 AM ET. The panel will be moderated by Killian Walsh, Managing Director, Structured Finance at KBRA, alongside other indust
For Immediate Release: December 10, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On December 9, 2021, the FDA updated the SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests web page to share the latest information. The update added new information about the Meridian Bioscience, Inc. Revogene SARS-CoV-2 test, inc
Mr. Harris was the lead battery responsible engineer at SpaceX, leading the engineering team that developed the battery systems of the Falcon 9 rocket, Cargo Dragon, and Crew Dragon spacecraft Appointment to Advisory Council bolsters VivoPower's power systems and battery engineering expertise across its sovereign AI data center platform, including operational Nordic sites as well as for Tembo, its electric vehicle business LONDON, June 02, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (NASDAQ:VIVO) ("VivoPower" or the "Company"), a B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications, today announced the appointment of Porter Har
Ms. Mustafa brings a track record from a 23-year tenure at Microsoft, where she headed Global Sales & Partnerships for Industrial Metaverse Core, in the Cloud & AI division of Microsoft Based between New York and Abu Dhabi, she was also formerly head of global partnerships for Core 42, which is part of G42, the Abu Dhabi headquartered AI group backed by Mubadala, Microsoft, Silverlake, and the Dalio Family Office LONDON, April 07, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (NASDAQ:VIVO) ("VivoPower" or the "Company"), a B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications, today announced the appointment of Khadija Mustafa to
CINCINNATI, Dec. 2, 2021 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that Bryan Baldasare, Executive Vice President, Chief Financial Officer, and Secretary, will retire from Meridian effective December 31, 2021. The Company is engaging an executive search firm in the recruitment of a new chief financial officer. The Company appointed Julie Smith to the position of Senior Vice President, Controller, effective December 6, 2021, and principal accounting officer, effective January 1, 2022.
Shareholders to Receive $34.00 Per Share in Cash, Providing Immediate, Compelling and Certain Value Transaction Follows Deliberate Review, Including Outreach to Potential Strategic and Financial Partners CINCINNATI and SEOUL, South Korea, July 7, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, and SD Biosensor, Inc. ("SDB") (KOSE: A137310) and SJL Partners LLC ("SJL") (collectively, the "Consortium") announced today that they have entered into a definitive merger agreement whereby a newly formed affiliate vehicle of the Consortium will acquire Meridian in an a
CINCINNATI, May 6, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced financial results for the second quarter ended March 31, 2022. Second Quarter Fiscal 2022 Highlights (Comparison to Second Quarter Fiscal 2021): Consolidated net revenues totaled $111.2 million, the highest in Company history, with both segments ahead of expectationsLife Science segment delivered record net revenues of $70.1 millionDiagnostics segment net revenues increased 29% year-over-year to a record $41.1 millionLaunched Lyo-Ready™ sample specific master mixes for bloodResumed
CINCINNATI, Ohio, May 2, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has acquired, through its subsidiary Meridian Life Science, Inc., substantially all of the assets of EUPROTEIN Inc. The transaction closed on April 30, 2022. EUPROTEIN Inc. offers custom development and production of high-quality bioresearch reagents, with a particular focus on human and other mammalian proteins and recombinant monoclonal antibodies. This acquisition will help
SC 13G/A - MERIDIAN BIOSCIENCE INC (0000794172) (Subject)
SC 13D/A - MERIDIAN BIOSCIENCE INC (0000794172) (Subject)
SC 13G/A - MERIDIAN BIOSCIENCE INC (0000794172) (Subject)